SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
0269881105058777v1
20/3/437    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rodgers, J.
Right arrow Articles by Scholey, A.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodgers, J.
Right arrow Articles by Scholey, A.B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*3,4-METHYLENEDIOXYMETHAMPHETAMINE
Medline Plus Health Information
*Club Drugs
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study

Jacqui Rodgers1*, Tom Buchanan2, Carol Pearson2, Andy C Parrott3, J. Ling4, T.M. Hefferman5, A.B. Scholey5

1 School of Neurology, Neurobiology and Psychiatry, University of Newcastle, Newcastle-upon-Tyne, UK.
2 Department of Psychology, University of Westminster, London, UK.
3 Department of Psychology, University of Wales Swansea, Swansea UK.
4 University of Teesside, Middlesborough, UK.
5 School of Psychology and Sport Sciences, Northumbria University, Newcastle-upon-Tyne, UK.

* To whom correspondence should be addressed.


   Abstract
Previous work provided preliminary evidence that different patterns of use among ecstasy users may impact on perceived side-effects. Participants recruited via an ecstasy-related bulletin board differed in their responses compared to those recruited via other means. The present investigation compares self-reports of psychobiological difficulties among ecstasy users recruited either via a bulletin board or by alternative methods. Qualitative data included reports of any negative or positive changes attributable to ecstasy use and reasons for cessation of use. An Internet-based design was utilized and 209 volunteers completed the study, 117 of whom were recruited via a bulletin board devoted to discussion of ecstasy. Psychobiological difficulties attributable to ecstasy use varied, with mood fluctuation the most common. Differences between the two groups in the extent to which these problems were reported was found. Bulletin board recruits were less likely to report anxiety or poor concentration, but more likely to report tremors/twitches. For the whole sample, lifetime use was associated more with psychobiologial problems, although this pattern was stronger and more pervasive for the non-bulletin board participants. Bulletin board recruits were more aware of possible negative psychological effects and were more likely to report adopting harm reduction strategies. From the qualitative data three negative consequences of use were identified, the most common of which was "psychological problems". In support of the quantitative findings the likelihood of reporting psychological problems increased with lifetime exposure to ecstasy in both recruitment conditions but interestingly this did not appear to impact on reasons for cessation of use. Participants also reported a number of effects that they regarded as beneficial. Future research should also take these aspects of use into account.

Key Words: MDMA, ecstasy, 3,4-methyleldioxymethamphetamine, side-effects, neuroprotection

First published on September 20, 2005, doi:10.1177/0269881105058777

Journal of Psychopharmacology 2006;20:437.

A more recent version of this article appeared on May 1, 2006


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
K Soar, A Parrott, and J Turner
Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users
J Psychopharmacol, September 1, 2009; 23(7): 745 - 758.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott, I. S. McGregor, T. M. C. Lee, A. B. Scholey, and M. J. Morgan
International conference on memory (ICOM-4), University of New South Wales, Sydney, Australia, 16 21 July 2006 Ecstasy/MDMA and Memory Symposium
J Psychopharmacol, November 1, 2007; 21(8): 895 - 897.
[PDF]



Advertisement